Results 211 to 220 of about 90,287 (254)
Some of the next articles are maybe not open access.

Vaccination of the immunocompromised host

Wiener Medizinische Wochenschrift, 2004
Vaccinations are safe and effective in immunocompromised patients. Apparently most vaccines in this patient population are underutilized. General vaccination recommendations are expressed for influenza, diphtheria and tetanus. Pneumococcal, meningococcal und Haemophilus influenzae B immunizations are specially indicated for patients with or developing ...
Andrew J, Ullmann   +2 more
openaire   +2 more sources

Sinusitis in the immunocompromised host

Current Infectious Disease Reports, 1999
Sinusitis occurs in a wide range of immunocompromised hosts, including neutropenic patients, diabetic patients, patients in critical care units, and patients with HIV infection. Reversal of underlying risk factors, such as neutropenia or diabetic ketoacidosis, is essential in the treatment of fungal rhinosinusitis.
openaire   +2 more sources

Madurella infection in an immunocompromised host

International Journal of Dermatology, 2000
A 77‐year‐old farmer, born and living in Sardinia, affected by acute myelogenous leukemia and undergoing chemotherapy treatment with cytosine arabinoside, presented at the Institute of Dermatology of Sassari in March 1998 with multiple subcutaneous lesions on the legs (Fig. 1) which had appeared 3 months previously.
SATTA, Rosanna Rita, Sanna S, Cottoni F.
openaire   +3 more sources

Management of the Immunocompromised Host

Medical Clinics of North America, 1984
This article deals with the management of the immunocompromised host. Mechanisms of immunocompromise include alterations in skin and mucosal barriers, normal oral and intestinal flora, splenic function, and number or function of T cells, B cells, granulocytes, and monocytes.
openaire   +2 more sources

[An immunocompromised host with a fever].

Nederlands tijdschrift voor geneeskunde, 2010
A 61-year-old woman with a hepatocellular carcinoma was admitted to the hospital for transplantation of the liver. She had a compromised immune system and developed a aspergillus pneumonia. The patient eventually died due to sepsis and multiple organ failure.
Witjes, Carlijn, Kazemier, G
openaire   +2 more sources

Lung biopsy in immunocompromised hosts

The American Journal of Medicine, 1975
Ninety-five lung biopsy procedures in 78 immunocompromised patients yielded treatable diagnoses in 35 per cent of the needle aspirates, 46 per cent of the cutting needle biopsies and 65 per cent of the open thoracotomies. Complication rates of bleeding or pneumothorax were comparable to those previously described in nonimmunocompromised patients.
R L, Greenman, P T, Goodall, D, King
openaire   +2 more sources

GASTROINTESTINAL INFECTIONS IN THE IMMUNOCOMPROMISED HOST

Infectious Disease Clinics of North America, 2001
Gastrointestinal disease is a significant cause of morbidity and mortality in the immunocompromised patient. This article focuses on the infectious gastrointestinal complications associated with the treatment of malignant disease and with solid organ transplantation but not HIV.
L R, Baden, J H, Maguire
openaire   +2 more sources

Recurrent orf in an immunocompromised host

British Journal of Plastic Surgery, 1991
A 30-year-old farmer with Nezelof's syndrome developed a giant orf on his hand. Recurrence followed surgical excision. Three excisions and split skin grafts were required before its eradication. He re-presented 8 years later with a further orf on the finger of his opposite hand.
S T, Tan, G B, Blake, S, Chambers
openaire   +2 more sources

CT of the Gut in the Immunocompromised Host

Radiologic Clinics of North America, 1989
The spread of the acquired immunodeficiency syndrome, the increasing popularity of bone marrow, renal, and other organ transplants, and the development of potent immunosuppressive drugs have produced a large population of immunocompromised hosts. These patients are at great risk for developing both opportunistic infections and neoplasms such as Kaposi ...
B, Jones, E K, Fishman
openaire   +2 more sources

Gastrointestinal mucormycosis in immunocompromised hosts

Mycoses, 2015
SummaryInvasive mucormycosis is a rare fungal infection in immunocompromised hosts, but it carries a high mortality rate. Primary gastrointestinal disease is the least frequent form of presentation. Early diagnosis and treatment are critical in the management; however, symptoms are typically non‐specific in gastrointestinal disease, leading to delayed ...
M Veronica, Dioverti   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy